Chinese Journal of Clinical Pharmacology and Therapeutics 2011 Issue 5 Significance of anti-cyclic citrullinated peptides antibodies in patients of systemic lupus erythematosus with arthritis

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Chinese Journal of Clinical Pharmacology and Therapeutics
1009-2501
2011 Issue 5

Significance of anti-cyclic citrullinated peptides antibodies in patients of systemic lupus erythematosus with arthritis
MAO Tong-jun;XU Guo-fei;SHENG Jun;LI Zhi;XUAN Dan;ZHANG Jun;LU Jin-ming;XU Liang

..............page:568-573

Biomarker finding of individual salviol B exposures in healthy subjects
HUANG Ji-han;WANG Kun;XU Ling;HE Ying-chun;LI Lu-jin;YANG Juan;SHENG Yu-cheng;ZHENG Qing-shan

..............page:510-516

Preliminary toxicological study of colchicine in rat renal cells NRK
CHEN Xue-mei;LIU Jun;SONG Jin-ping;WANG Tao;SHANG Jing

..............page:496-500

Effect of silencing CTLA4 with siRNA on the Th1/Th2 cytokines in peripheral blood of chronic hepatitis B patient
YU Yong-sheng;WU Hao;TANG Zheng-hao;ZANG Guo-qing

..............page:553-558

Acupuncture for migraine: a systematic review and meta-analysis of randomized controlled trials
GAO Xiao-mei;WANG Bo-song;SONG Yan-yan;QI Hong;RONG Zheng-xing;WANG Hao

..............page:530-537

Progression of no-reflow prevention and treatment in percutaneous coronary intervention
LI Xiao-qian;KE Yong-sheng

..............page:595-600

Effects of regular consumption of RRR-α-tocopherol on the activity of P-gp in vivo
ZHANG Song-bo;DUAN Juan;ZHOU Hong-hao

..............page:545-548

Recent progress of aldose reductase in non-diabetic disease
DENG Xiao-lan;LI Hui;JING Xian;TIAN Ying-ying;LV Pei-yu;OUYANG Dong-sheng

..............page:590-594

Exact method of sample size calculation and statistical inference in single-arm clinical trials with objective performance criteria
CHENG Qi;LIU Yu-xiu;CHEN Lin;LIU Li-xia

..............page:517-522

Research approaches of CYP450s\' induction/inhibition and their application on drug development
BU Ming-hua;ZHANG Ying;LIU Jian-xun;LIU Dong-chun

..............page:579-585

Simultaneous determination of 10 amino acids in serum by reversed phase high performance liquid chromatography with pre-column phenylisothiocyanate derivatization
YANG Zhi;YANG Li-long;ZHU Wen-bing;CAO Jing;HE Zhou-kang

..............page:549-552

Effects of magnesium lithospermate B on the expression of heme oxygenase-1 in HEK293T cells
REN Xian;HOU Rui-ying;QU Jian;SHEN Jie;ZHOU Hong-hao;LIU Zhao-qian

..............page:481-487

Study on metabolic risk of first-episode acute schizophrenia patients treated with aripiprazole
WU Xiao-li;WEN Fei;ZHONG Zhi-yong;HAN Zi-li

..............page:563-567

xin xi dong tai

..............page:505,578

Ezetimibe inhibiting intracellular lipid accumulation through caveolin-1 in rat vascular smooth muscle cells
TUO Qin-hui;YUAN Hao-yu;GUO Yan;YU Wei-xia;LIAO Duan-fang

..............page:492-495

Effects of study duration and interview duration on allocation proportions randomized by urn model in clinical trial
YU Li-li;BU Xiao-dong;LIU Zhao-ping;LI Xia;XIA Jie-lai

..............page:506-509

Effects of Lipo-prostaglandin E1 on diabetic peripheral neuropathy:A meta-analysis
LIU Lin;HUO Mo-fei;SUN Rui-hua

..............page:523-529

Efficacy study of Escitalopram together with atypical antipsychotic in treating depression symptoms accompanied with acute schizophrenia
JIANG Chang-wang;SHI Jian-fei;ZHU Ya-ping;TAO Yun-hai

..............page:574-578

Clinical analysis of therapeutic drug monitoring and drug dosage for ICU patients treated with teicoplanin
LI Hao;WANG Xue;DONG Hai-yan;DONG Ya-lin;TIAN Gang

..............page:538-544

Compare study of clinical features in polymyositis and dermatomyositis
XUAN Dan;SHENG Jun;LI Zhi;MAO Tong-jun;XU Liang;LU Jin-ming

..............page:558-562

Change of p-CREB in the protection effect of agitating gamma-hydroxybutyric acid receptor on focal cerebral ischemia-reperfusion injury in rats
YANG Qi-xia;QIN Hao;GU Shu-ling

..............page:488-491

Design idea and methodology for the II and III clinical trial of the new drugs in view of effectiveness and ethics
BI Jing-feng;CHEN Su-hong;WEI Zhen-man

..............page:586-589

Cell research on anaphylactoid reaction induced by pharmaceutical excipients Polysorbate 80
LI Qin;ZHAO Yin;ZHENG Xiao-liang;ZHANG Xin-yue

..............page:501-505